Contracts › 75A50123C00028
75A50123C00028: Research and Development- Aoi #16+ Seeking to Manufacture and Obtain Regulatory Approval for the Cytotracker Bv, a Point-Of-Care Instant White Blood Cell Analysis Platform for Discriminating Between Acute Viral and Bacterial Infections.
Awarded to Rizlab Health Inc by Office of Assistant Secretary for Preparedness and Response.
$2.5Mobligated
$2.5Mpotential value
10 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50123C00028 |
|---|---|
| Awardee | Rizlab Health Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 11 August 2023 to 10 April 2027 |
| Potential end | 10 April 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record